Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MEDIFAST INC Director's Dealing 2023

Aug 16, 2023

33899_dirs_2023-08-16_ef398ceb-fe95-443d-b186-823688ef015a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2023-08-14

Reporting Person: BROWN JEFFREY J (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-08-14 Common Stock S 15154 $92.60 Disposed 23162.638 Indirect
2023-08-15 Common Stock S 9832 $89.79 Disposed 13330.638 Indirect
2023-08-15 Common Stock S 13330 $90.47 Disposed 0.638 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 5725.295 Direct
Common Stock 4136.231 Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.50 to $92.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1, 3, and 4 herein.

F2: These shares were held by Brown Equity Partners, LLC ("BEP"), for which the reporting person is the managing member.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.36 to $89.96, inclusive.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.03 to $90.93, inclusive.

F5: These shares are directly owned by Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary.